Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt
· Delayed Price · Currency is EGP 4.550
-0.060 (-1.30%)
At close: Apr 28, 2026
EGX:RMDA Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 36.18 | 64.69 | 52.36 | 66.96 | 14 | Upgrade
|
| Short-Term Investments | - | 189.7 | 260.9 | 361.86 | 468.01 | Upgrade
|
| Cash & Short-Term Investments | 36.18 | 254.39 | 313.25 | 428.82 | 482.01 | Upgrade
|
| Cash Growth | -85.78% | -18.79% | -26.95% | -11.04% | -0.12% | Upgrade
|
| Accounts Receivable | 1,027 | 791.26 | 353.74 | 276.6 | 265.96 | Upgrade
|
| Other Receivables | 62.48 | 103.43 | 72.16 | 22.6 | 25.2 | Upgrade
|
| Receivables | 2,178 | 1,582 | 1,344 | 923.28 | 684.61 | Upgrade
|
| Inventory | 1,031 | 751.34 | 303.26 | 348.41 | 259.4 | Upgrade
|
| Prepaid Expenses | 10.49 | 4.29 | 2.21 | 2.83 | 0.99 | Upgrade
|
| Other Current Assets | 178.67 | 544.65 | 60.33 | 55.14 | 48.64 | Upgrade
|
| Total Current Assets | 3,435 | 3,137 | 2,023 | 1,758 | 1,476 | Upgrade
|
| Property, Plant & Equipment | 792.15 | 621.52 | 606.05 | 556.98 | 554.99 | Upgrade
|
| Other Intangible Assets | 1,111 | 552.79 | 589.27 | 457.57 | 389.66 | Upgrade
|
| Total Assets | 5,338 | 4,311 | 3,218 | 2,773 | 2,420 | Upgrade
|
| Accounts Payable | 335.19 | 264.36 | 102.41 | 120.25 | 61.53 | Upgrade
|
| Accrued Expenses | 154.76 | 115.09 | 76.44 | 62.92 | 37.31 | Upgrade
|
| Short-Term Debt | 2,326 | 1,555 | 1,098 | 910.18 | 842.6 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 21.95 | Upgrade
|
| Current Portion of Leases | 6.76 | 4.48 | 4.81 | 3.66 | 3.13 | Upgrade
|
| Current Income Taxes Payable | 116.58 | 98.78 | 60.59 | 53.71 | 33.49 | Upgrade
|
| Other Current Liabilities | 43.98 | 117.77 | 30.67 | 31.23 | 22.05 | Upgrade
|
| Total Current Liabilities | 2,984 | 2,155 | 1,373 | 1,182 | 1,022 | Upgrade
|
| Long-Term Leases | 75.46 | 7.19 | 11.7 | 16.34 | 12.26 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 68.57 | 77.28 | 58.23 | 51.56 | 40.5 | Upgrade
|
| Total Liabilities | 3,128 | 2,240 | 1,443 | 1,250 | 1,075 | Upgrade
|
| Common Stock | 500 | 378.23 | 375 | 250 | 250 | Upgrade
|
| Additional Paid-In Capital | 255.79 | 327.51 | 377.7 | 397.52 | 486.97 | Upgrade
|
| Retained Earnings | 1,399 | 1,351 | 1,022 | 921.68 | 610.87 | Upgrade
|
| Treasury Stock | - | -26.23 | -26.23 | -65.93 | - | Upgrade
|
| Comprehensive Income & Other | 13.04 | 13.31 | 14.21 | 15.31 | 0.28 | Upgrade
|
| Total Common Equity | 2,168 | 2,044 | 1,763 | 1,519 | 1,348 | Upgrade
|
| Minority Interest | 42.12 | 27.38 | 12.94 | 4.59 | -2.62 | Upgrade
|
| Shareholders' Equity | 2,210 | 2,072 | 1,775 | 1,523 | 1,345 | Upgrade
|
| Total Liabilities & Equity | 5,338 | 4,311 | 3,218 | 2,773 | 2,420 | Upgrade
|
| Total Debt | 2,409 | 1,566 | 1,114 | 930.18 | 879.94 | Upgrade
|
| Net Cash (Debt) | -2,372 | -1,312 | -801.18 | -501.37 | -397.93 | Upgrade
|
| Net Cash Per Share | -1.18 | -0.65 | -0.40 | -0.26 | -0.20 | Upgrade
|
| Filing Date Shares Outstanding | 2,000 | 1,990 | 1,973 | 1,973 | 2,015 | Upgrade
|
| Total Common Shares Outstanding | 2,000 | 1,990 | 1,973 | 1,956 | 2,015 | Upgrade
|
| Working Capital | 450.99 | 981.82 | 650.11 | 576.53 | 453.59 | Upgrade
|
| Book Value Per Share | 1.08 | 1.03 | 0.89 | 0.78 | 0.67 | Upgrade
|
| Tangible Book Value | 1,057 | 1,491 | 1,173 | 1,061 | 958.45 | Upgrade
|
| Tangible Book Value Per Share | 0.53 | 0.75 | 0.59 | 0.54 | 0.48 | Upgrade
|
| Land | 18.64 | 18.64 | 18.64 | 18.64 | 18.64 | Upgrade
|
| Buildings | 300.43 | 294.77 | 288.43 | 279.17 | 273.34 | Upgrade
|
| Machinery | 726.8 | 646.31 | 585.04 | 533.6 | 491.55 | Upgrade
|
| Construction In Progress | 94.15 | 33.46 | 38.09 | 12.86 | 27.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.